Pot Chl/d5w 20meq/l Inj, 1000ml

Manufacturer FRESENIUS KABI USA Active Ingredient Intravenous (IV) Fluids(in truh VEE nuhs FLOO ids) Pronunciation POH-tass-ee-um KLOR-ide in DEX-trohs FIE per-SENT in WAH-ter for IN-jek-shun
It is used to give fluids to the body when more fluids and electrolytes are needed.It is used as a way to give other drugs as a shot.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Fluid and electrolyte replacement; Parenteral nutrition adjunct
đŸ§Ŧ
Pharmacologic Class
Electrolyte (potassium); Carbohydrate (dextrose); Intravenous solution
🤰
Pregnancy Category
Category C
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is an intravenous (IV) fluid that provides your body with essential water, sugar (dextrose) for energy, and potassium, which is a vital mineral. It's used to replace fluids and electrolytes that your body might be lacking, for example, due to dehydration, vomiting, diarrhea, or certain medical conditions. It helps maintain normal heart function, muscle activity, and nerve signals.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered as an infusion into a vein over a period of time. Your doctor may instruct you on how to self-administer this medication.

Preparation and Administration

Before and after handling the medication, wash your hands thoroughly. Do not use the solution if it appears cloudy, is leaking, or contains particles. Additionally, do not use the solution if it has changed color.

Safe Disposal

Dispose of needles and other sharp objects in a designated needle/sharp disposal box. Do not reuse needles or other items. When the disposal box is full, follow local regulations for proper disposal. If you have any questions or concerns, consult your doctor or pharmacist.

Storage and Disposal

Typically, this medication is administered in a hospital or doctor's office. If you need to store it at home, follow the storage instructions provided by your doctor.

Missed Dose

If you miss a dose, contact your doctor to determine the best course of action.
💡

Lifestyle & Tips

  • This medication is administered in a healthcare setting by a professional. No specific lifestyle modifications are required by the patient related to its administration.
  • Report any unusual symptoms or discomfort during the infusion, such as pain at the injection site, swelling, shortness of breath, or changes in heart rate.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly individualized based on patient's fluid and electrolyte status, serum potassium levels, and clinical condition. Typical potassium replacement rates are 10-20 mEq/hour, not exceeding 40 mEq/hour in severe cases with continuous ECG monitoring. Fluid volume (1000ml) is administered based on hydration needs.

Condition-Specific Dosing:

hypokalemia: Dosage and rate depend on severity of hypokalemia and patient's renal function. Usually 10-20 mEq/hour, up to 40 mEq/hour in severe cases with continuous ECG monitoring.
maintenance: Typically 20-60 mEq/day of potassium, administered as part of total parenteral fluid requirements.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for this specific concentration; highly individualized based on weight, fluid status, and electrolyte levels. Typically 0.5-1 mEq/kg/day of potassium for maintenance, or 0.25-0.5 mEq/kg/hour for replacement.
Infant: Highly individualized based on weight, fluid status, and electrolyte levels. Typically 0.5-1 mEq/kg/day of potassium for maintenance, or 0.25-0.5 mEq/kg/hour for replacement.
Child: Highly individualized based on weight, fluid status, and electrolyte levels. Typically 0.5-1 mEq/kg/day of potassium for maintenance, or 0.25-0.5 mEq/kg/hour for replacement.
Adolescent: Highly individualized based on weight, fluid status, and electrolyte levels. Dosing approaches adult recommendations as weight increases.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor serum potassium closely.
Moderate: Significant dose reduction or avoidance may be necessary; monitor serum potassium and renal function frequently. Risk of hyperkalemia is increased.
Severe: Generally contraindicated due to high risk of severe hyperkalemia. If absolutely necessary, administer with extreme caution and continuous ECG monitoring, at very low rates.
Dialysis: Contraindicated in anuric patients. In patients on dialysis, potassium requirements are highly variable and should be determined by frequent serum potassium monitoring. May be needed post-dialysis if hypokalemic.

Hepatic Impairment:

Mild: No specific dose adjustment required, but monitor fluid balance.
Moderate: No specific dose adjustment required, but monitor fluid balance and electrolyte levels due to potential for fluid retention or electrolyte disturbances.
Severe: No specific dose adjustment required for potassium, but careful monitoring of fluid balance and electrolyte levels is crucial due to potential for ascites, edema, and dilutional hyponatremia.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Potassium Chloride provides potassium, the major intracellular cation, essential for maintaining intracellular tonicity, nerve impulse transmission, cardiac contraction, and skeletal and smooth muscle function. It is also involved in carbohydrate metabolism and protein synthesis. Dextrose 5% in Water provides a source of calories (170 kcal/L) and free water, which is distributed throughout the total body water, promoting renal solute excretion and preventing ketosis.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (intravenous administration)
Tmax: Rapid (immediate distribution upon infusion)
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Potassium: Approximately 0.5 L/kg (total body water); Dextrose: Distributed throughout total body water.
ProteinBinding: Potassium: Negligible; Dextrose: Negligible
CnssPenetration: Yes (both components distribute to CNS)

Elimination:

HalfLife: Potassium: Not applicable (homeostatically regulated); Dextrose: Not applicable (metabolized)
Clearance: Potassium: Primarily renal (glomerular filtration and tubular secretion/reabsorption); Dextrose: Metabolized
ExcretionRoute: Potassium: Urine (primarily), feces, sweat; Dextrose: Metabolized to CO2 and H2O
Unchanged: Potassium: >90% renally excreted unchanged; Dextrose: Negligible
âąī¸

Pharmacodynamics

OnsetOfAction: Rapid (within minutes of infusion)
PeakEffect: Achieved during infusion, dependent on infusion rate and patient's metabolic state.
DurationOfAction: Dependent on patient's fluid and electrolyte balance, renal function, and ongoing losses. Effects persist as long as infusion continues and for a period thereafter until homeostasis is restored.
Confidence: Medium

Safety & Warnings

âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Fast or abnormal heartbeat
+ Severe dizziness or passing out
+ Increased thirst
+ Seizures
+ Feeling very tired or weak
+ Decreased appetite
+ Unable to pass urine or change in the amount of urine produced
+ Dry mouth
+ Dry eyes
+ Severe upset stomach or vomiting
Signs of skin infection, such as:
+ Oozing
+ Heat
+ Swelling
+ Redness
+ Pain
Swelling, warmth, numbness, change of color, or pain in a leg or arm
Chest pain or pressure
Fever
Shortness of breath
Sudden weight gain
Swelling in the arms or legs

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:

Irritation or swelling at the injection site
* Pain at the injection site

This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Muscle weakness or numbness/tingling (paresthesias)
  • Feeling tired or fatigued
  • Slow or irregular heartbeat
  • Shortness of breath or difficulty breathing
  • Swelling in the ankles, feet, or hands
  • Headache or confusion
  • Pain or redness at the IV site
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
Potential interactions with other medications or health conditions. This medication may interact with other drugs or exacerbate certain health problems.

To ensure safe use, provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are currently taking
Any natural products or vitamins you are using
* Existing health problems or conditions

It is crucial to verify that it is safe to take this medication in conjunction with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

If your medication contains potassium, consult with your doctor before using any salt substitutes or products that also contain potassium.

If your medication contains dextrose and you have diabetes (high blood sugar), discuss this with your doctor to ensure safe management of your condition.

Regular blood tests will be necessary as directed by your doctor. Be sure to follow their instructions and discuss any concerns or questions you may have.

When administering this medication to newborns, exercise caution due to a potentially higher risk of side effects in this age group.

If you are pregnant, planning to become pregnant, or are breastfeeding, it is crucial to discuss the benefits and risks of this medication with your doctor to make an informed decision regarding your health and the health of your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Hyperkalemia (high potassium): muscle weakness, flaccid paralysis, paresthesias, bradycardia, hypotension, cardiac arrhythmias (e.g., peaked T waves, widened QRS, ventricular fibrillation, asystole)
  • Fluid Overload: peripheral edema, pulmonary edema, hypertension, jugular venous distension, headache, nausea, vomiting

What to Do:

Immediate medical attention is required. Management involves discontinuing the infusion, administering calcium gluconate (for cardiac protection), insulin with dextrose (to shift potassium intracellularly), sodium bicarbonate, loop diuretics, or potassium-binding resins. Dialysis may be necessary in severe cases. Call 911 or 1-800-222-1222 (Poison Control) immediately.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene) in patients with renal impairment or significant hyperkalemia risk
  • ACE inhibitors (e.g., lisinopril, enalapril) and Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan) in patients with renal impairment or significant hyperkalemia risk
  • Aliskiren in patients with renal impairment or significant hyperkalemia risk
🔴

Major Interactions

  • Potassium-sparing diuretics (increased risk of hyperkalemia)
  • ACE inhibitors (increased risk of hyperkalemia)
  • Angiotensin Receptor Blockers (ARBs) (increased risk of hyperkalemia)
  • Non-steroidal anti-inflammatory drugs (NSAIDs) (may impair renal potassium excretion, increasing hyperkalemia risk)
  • Cyclosporine, Tacrolimus (increased risk of hyperkalemia)
  • Digoxin (hyperkalemia can antagonize digoxin effects; hypokalemia potentiates digoxin toxicity)
  • Insulin (can shift potassium intracellularly, potentially masking hyperkalemia or causing transient hypokalemia if not balanced)
  • Beta-blockers (non-selective) (may impair cellular potassium uptake, increasing hyperkalemia risk)
  • Succinylcholine (can cause acute increase in serum potassium, especially in patients with neuromuscular disease or burns)
🟡

Moderate Interactions

  • Corticosteroids (may increase potassium excretion, potentially requiring higher potassium doses)
  • Diuretics (loop or thiazide) (may cause hypokalemia, necessitating potassium supplementation)
  • Sodium polystyrene sulfonate (Kayexalate) (used to treat hyperkalemia, but can cause hypokalemia if overused with potassium supplementation)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Electrolytes (Na, K, Cl, CO2)

Rationale: To assess baseline fluid and electrolyte status, especially potassium levels, and guide initial dosing.

Timing: Prior to initiation of therapy.

Renal Function (BUN, Creatinine)

Rationale: To assess kidney's ability to excrete potassium and prevent hyperkalemia.

Timing: Prior to initiation of therapy.

Fluid Status (Weight, I&O, Vital Signs)

Rationale: To assess hydration status and guide fluid volume administration.

Timing: Prior to initiation of therapy.

Electrocardiogram (ECG)

Rationale: To assess cardiac rhythm and identify signs of hypokalemia or hyperkalemia, especially in patients with pre-existing cardiac conditions or rapid potassium replacement.

Timing: Prior to initiation, especially if potassium is severely low or high.

📊

Routine Monitoring

Serum Potassium

Frequency: Every 2-6 hours during rapid replacement; daily for maintenance; more frequently in patients with renal impairment or critical illness.

Target: 3.5-5.0 mEq/L

Action Threshold: <3.0 mEq/L (increase rate/dose), >5.5 mEq/L (decrease rate/dose, consider intervention for hyperkalemia)

Serum Electrolytes (Na, Cl, CO2)

Frequency: Daily or as clinically indicated.

Target: Normal ranges

Action Threshold: Abnormal values warrant investigation and correction.

Renal Function (BUN, Creatinine)

Frequency: Daily or every other day, especially in patients with impaired renal function.

Target: Stable within patient's baseline

Action Threshold: Significant increase indicates worsening renal function, requiring potassium dose adjustment.

Fluid Balance (Intake & Output, Daily Weight)

Frequency: Every 4-8 hours (I&O), daily (weight).

Target: Appropriate balance for patient's condition (e.g., even balance, negative balance for fluid overload)

Action Threshold: Significant positive or negative balance, or rapid weight changes, indicate fluid imbalance.

Vital Signs (BP, HR, RR)

Frequency: Every 4-8 hours or as clinically indicated.

Target: Within normal limits for patient

Action Threshold: Significant changes may indicate fluid overload, dehydration, or electrolyte imbalance.

Electrocardiogram (ECG)

Frequency: Continuous monitoring during rapid potassium replacement (>10 mEq/hr) or in patients with significant hyperkalemia/hypokalemia.

Target: Normal sinus rhythm, absence of hyperkalemic/hypokalemic changes (e.g., peaked T waves, prolonged PR/QRS, U waves)

Action Threshold: Presence of arrhythmias or characteristic ECG changes warrants immediate intervention.

Blood Glucose

Frequency: Every 4-6 hours initially, then daily, especially in diabetic patients or those receiving high dextrose loads.

Target: 70-180 mg/dL

Action Threshold: <70 mg/dL or >180 mg/dL (requires intervention)

đŸ‘ī¸

Symptom Monitoring

  • Signs of hyperkalemia: muscle weakness, paresthesias, flaccid paralysis, fatigue, bradycardia, irregular heartbeat, confusion.
  • Signs of fluid overload: peripheral edema, pulmonary edema (shortness of breath, crackles), jugular venous distension, hypertension, headache.
  • Signs of hypokalemia (if inadequate replacement): muscle weakness, cramps, fatigue, constipation, palpitations, polyuria, polydipsia.

Special Patient Groups

🤰

Pregnancy

Category C. Use only if clearly needed and the potential benefits outweigh the potential risks to the fetus. Careful monitoring of maternal fluid and electrolyte balance is crucial.

Trimester-Specific Risks:

First Trimester: No specific data indicating increased risk of congenital anomalies. Use only if clinically indicated.
Second Trimester: Generally considered safe when indicated for fluid and electrolyte balance, with careful monitoring.
Third Trimester: Careful monitoring of fluid and electrolyte balance is essential, especially to avoid fluid overload or electrolyte imbalances that could affect the mother or fetus.
🤱

Lactation

L3 (Moderately Safe). Potassium and dextrose are normal components of breast milk. Administration of this solution is unlikely to cause adverse effects in a nursing infant when used appropriately to correct maternal fluid and electrolyte imbalances. Monitor infant for any unusual symptoms.

Infant Risk: Low risk when used appropriately. Monitor for signs of fluid overload or electrolyte imbalance in the infant, though unlikely.
đŸ‘ļ

Pediatric Use

Requires extreme caution and precise dosing based on weight, age, and clinical condition. Children, especially neonates and infants, have immature renal function and are more susceptible to fluid overload and electrolyte imbalances (both hypokalemia and hyperkalemia). Frequent monitoring of serum electrolytes, glucose, and fluid balance is essential.

👴

Geriatric Use

Elderly patients are more susceptible to fluid overload and electrolyte imbalances due to age-related decline in renal function, cardiac reserve, and altered fluid regulation. Initiate therapy with lower doses and slower infusion rates. Frequent monitoring of fluid status, renal function, and serum electrolytes is crucial.

Clinical Information

💎

Clinical Pearls

  • Always verify the concentration of potassium chloride before administration to prevent medication errors. 20 mEq/L is a common maintenance concentration, but higher concentrations are used for replacement.
  • Potassium should never be administered as an IV push or undiluted, as this can cause fatal cardiac arrhythmias.
  • Infusion rates for potassium replacement should generally not exceed 10 mEq/hour in peripheral veins or 20 mEq/hour in central veins, unless in critical care settings with continuous ECG monitoring for severe hypokalemia.
  • Ensure adequate urine output before administering potassium to prevent hyperkalemia.
  • Monitor ECG for signs of hyperkalemia (peaked T waves, widened QRS, prolonged PR) or hypokalemia (flattened T waves, U waves, ST depression).
  • Dextrose solutions can cause hyperglycemia, especially in diabetic patients or those under stress. Monitor blood glucose levels.
  • This solution provides free water, which can lead to dilutional hyponatremia if administered excessively or in patients with impaired water excretion (e.g., SIADH, heart failure).
  • Assess for signs of phlebitis or extravasation at the infusion site, especially with higher potassium concentrations.
🔄

Alternative Therapies

  • Oral potassium supplements (for mild to moderate hypokalemia)
  • Other intravenous fluid types (e.g., Lactated Ringer's, Plasma-Lyte, 0.9% Sodium Chloride) depending on specific fluid and electrolyte needs.
  • Potassium-rich foods (for dietary maintenance)
💰

Cost & Coverage

Average Cost: $5 - $20 per 1000ml bag
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred.